Teva rejected opportunity to acquire Perrigo

Teva declined the chance because it does not operate in the store-brand OTC market, Perrigo's main activity.

(L_R) Teva CEO EREZ VIGODMAN and PERRIGO CEO Joseph Papa

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) had an opportunity to acquire US pharmaceuticals company Perrigo Company (NYSE:PRGO; TASE:PRGO) a few months ago, and said it was not interested, sources inform “Globes.” Perrigo hired bankers last summer to assess the possibility of its sale via a merger with a large pharmaceuticals company, and those bankers approached Teva and proposed that it acquire Perrigo….  [READ MORE]

Published by Globes [online], Israel business news – www.globes-online.com

***

READ MORE:

 

 

Read more about: , , , , , , , , , , , ,

Wordpress site Developed by Fixing WordPress Problems